Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Immunotherapy with monoclonal antibodies (MoAbs) targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and the programmed death-1 receptor (PD-1) and it
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Annals of oncology
Year: 2017, Jahrgang: 28, Pages: iv119-iv142 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx225 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdx225
|
| Verfasserangaben: | J.B.A.G. Haanen, F. Carbonnel, C. Robert, K.M. Kerr, S. Peters, J. Larkin, K. Jordan |
| Zusammenfassung: | Immunotherapy with monoclonal antibodies (MoAbs) targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and the programmed death-1 receptor (PD-1) and it |
|---|---|
| Beschreibung: | Available online 6 January 2020 Gesehen am 23.04.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx225 |